The platelet-activating factor receptor antogonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats

Journal of Pediatric Gastroenterology and Nutrition

Volumn 24, Issue 3, 1997, Pages 296-301

  Caplan, Michael S ^a   Hedlund, Erik ^a   Adler, Luba ^a   Lickerman, Matthew ^a   Hsueh, Wei ^b  

^a EVANSTON HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Necrotizing enterocolitis; Platelet activating factor antagonist

Indexed keywords

APAFANT; BEPAFANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DOSE RESPONSE; ENTEROBACTER INFECTION; FEMALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; AZEPINES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; INTESTINE, SMALL; INTESTINES; NECROSIS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; TRIAZOLES;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROBACTER;

EID: 0030969473     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199703000-00012     Document Type: Article

References (30)

1. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Philips JB, Wright LL. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. J Pediatr 1991;119:630-8.
2. Kliegman RM, Fanaroff AA. Necrotizing enterocolitis. N Engl J Med 1984;310:1093-103.
3. Brown EG, Sweet AY. Neonatal necrotizing enterocolitis. Pediatr Clin North Am 1982;29:1149-70.
4. Gonzalez-Crussi F, Hsueh W. Experimental model of ischemic bowel necrosis: the role of platelet-activating factor and endotoxin. Am J Pathol 1983;112:127-35.
5. Hsueh W, Gonzalez-Crussi F, Arroyave JL. Platelet activating factor is an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987;1:403-5.
6. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259:C697-708.
7. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem 1986;55:483-509.
8. Kubes P, Arfors KE, Granger DE. Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. Am J Physiol 1991;260:G965-71.
9. Furukawa M, Lee E, Johnston JM. Platelet-activating factor-induced ischemic bowel necrosis: the effect of PAF acetylhydrolase. Pediatr Res 1993;34:237-41.
10. Sun X-M, Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988;81:1328-31.
11. Caplan MS, Sun X-M, Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology 1990;99:979-86.
12. Mozes T, Braquet P, Filep J. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 1989;257:R872-7.
13. Caplan MS, Hedlund E, Hill N, MacKendrick W. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994;106:346-52.
14. Hsueh W, Gonzlez-Crussi F, Arroyave JL, Anderson RC, Lee ML, Houlihan WJ. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. Eur J Pharmacol 1986;123:79-83.
15. Caplan MS, Sun X-M, Hsueh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990;116:960-4.
16. MacKendrick W, Hill N, Hsueh W, Caplan M. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate 1993;64:89-95.
17. Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, Schullinger JN. An experimental study of acute neonatal enterocolitis: the importance of breast milk. J Pediatr Surg 1974;9:587-94.
18. Caplan MS, Hedlund E, Adler L, Hsueh W. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol 1994;14:1017-28.
19. Heuer HO. Current status of PAF antagonists. Clin Exp Allergy 1992;22:980-3.
20. Koltai M, Guinot P, Hosford D, Braquet PG. Platelet-activating factor antagonists: scientific background and possible clinical applications. Adv Pharmacol 1994;28:81-167.
21. Pitt J, Barlow B, Weird WC. Protection against experimental necrotizing enterocolitis by maternal milk. I. Role of milk leukocytes. Pediatr Res 1977;11:906-9.
22. Israel EJ, Schiffrin EJ, Carter EA, Freiberg E, Walker WA. Prevention of necrotizing enterocolitis in the rat with prenatal cortisone. Gastroenterology 1990;99:1333-8.
23. Schmidt J, Lindstaedt R, Szelenyi I. Characterization of platelet-activating factor induced superoxide anion generation by guinea-pig alveolar macrophages. J Lipid Mediat 1992;5:13-22.
24. Hu W, McNicholl IK, Choy PC, Man RYK. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Br J Pharmacol 1993;110:645-50.
25. 2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor. Gut 1994;35:215-9.
26. Zhang C, Hsueh W, Caplan MS, Kelly A. Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991;19:1067-72.
27. Kliegman RM. Models of the pathogenesis of necrotizing enterocolitis. J Pediatr 1990;117:52-5.
28. Scheifele D, Olsen E, Fussell S, Pendray M. Spontaneous endotoxinemia in premature infants: correlations with oral feeding and bowel dysfunction. J Pediatr Gastroenterol Nutr 1985;4:67-74.
29. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-4.
30. Denizot Y, Dassa E, Benveniste J, Thomas Y. PAF-acether production by Escherichia coli. Biochem Biophys Res Commun 1989;161:939-43.